EP1011681A1 - Orale kontrazeptive zubereitung enthaltend eine erste phase enthaltende eine kombination von gestagen/estrogen und eine zweite phase enthaltend gestagen - Google Patents

Orale kontrazeptive zubereitung enthaltend eine erste phase enthaltende eine kombination von gestagen/estrogen und eine zweite phase enthaltend gestagen

Info

Publication number
EP1011681A1
EP1011681A1 EP98944837A EP98944837A EP1011681A1 EP 1011681 A1 EP1011681 A1 EP 1011681A1 EP 98944837 A EP98944837 A EP 98944837A EP 98944837 A EP98944837 A EP 98944837A EP 1011681 A1 EP1011681 A1 EP 1011681A1
Authority
EP
European Patent Office
Prior art keywords
days
combination
levonorgestrel
administered
progestin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98944837A
Other languages
English (en)
French (fr)
Inventor
Michael Jay Gast
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Publication of EP1011681A1 publication Critical patent/EP1011681A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP98944837A 1997-09-12 1998-09-09 Orale kontrazeptive zubereitung enthaltend eine erste phase enthaltende eine kombination von gestagen/estrogen und eine zweite phase enthaltend gestagen Withdrawn EP1011681A1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US92853097A 1997-09-12 1997-09-12
US928530 1997-09-12
PCT/US1998/018850 WO1999013882A1 (en) 1997-09-12 1998-09-09 Oral contraceptive preparation having a first phase comprising progestin/estrogen and a second phase comprising progestin

Publications (1)

Publication Number Publication Date
EP1011681A1 true EP1011681A1 (de) 2000-06-28

Family

ID=25456367

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98944837A Withdrawn EP1011681A1 (de) 1997-09-12 1998-09-09 Orale kontrazeptive zubereitung enthaltend eine erste phase enthaltende eine kombination von gestagen/estrogen und eine zweite phase enthaltend gestagen

Country Status (6)

Country Link
EP (1) EP1011681A1 (de)
JP (1) JP2001516720A (de)
CN (1) CN1270521A (de)
AU (1) AU759925B2 (de)
CA (1) CA2301162A1 (de)
WO (1) WO1999013882A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001030355A1 (fr) * 1999-10-25 2001-05-03 Laboratoire Theramex Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
FR2754179B1 (fr) 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
WO2003041719A1 (en) * 2001-11-15 2003-05-22 Pantarhei Bioscience B.V. Method of contraception in mammalian females and pharmaceutical kit for use in such method
BRPI0214716B8 (pt) 2001-12-05 2021-05-25 Teva Womens Health Inc kit, preparos, e uso de estrogênio e progestina na fabricação de um medicamento para uso na prevenção de gravidez
CA2478165A1 (en) * 2002-03-11 2003-09-25 Janssen Pharmaceutica N.V. Sulfatase inhibiting progestogen-only contraceptive regimens
JP2005519963A (ja) * 2002-03-11 2005-07-07 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 長期サイクルのエストロゲンおよびスルファターゼ阻害プロゲストゲン避妊レジメン
WO2003077925A1 (en) * 2002-03-11 2003-09-25 Janssen Pharmaceutica N.V. Sulfatase inhibiting continuous progestogen contraceptive regimens
US20070111975A1 (en) 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
CN104546870B (zh) * 2015-01-27 2018-01-12 唐凡兰 一种避孕药

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0368373A1 (de) * 1988-10-13 1990-05-16 Akzo Nobel N.V. Mehrphasisches kontrazeptives Präparat
DE19549264A1 (de) * 1995-12-23 1997-06-26 Schering Ag Verfahren und Kit zur Kontrazeption

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9913882A1 *

Also Published As

Publication number Publication date
CN1270521A (zh) 2000-10-18
AU759925B2 (en) 2003-05-01
AU9228698A (en) 1999-04-05
CA2301162A1 (en) 1999-03-25
WO1999013882A1 (en) 1999-03-25
JP2001516720A (ja) 2001-10-02

Similar Documents

Publication Publication Date Title
US5858405A (en) Oral contraceptive
US5888543A (en) Oral contraceptives
US5747480A (en) Oral contraceptive
EP0956024B1 (de) Orale einstufige empfängnisverhütungsmethode und kombinationspräparat das gestagen und estrogen enthält
US6479475B1 (en) Oral contraceptive
WO1998004246A2 (en) Triphasic contraceptive method and kit comprising a combination of a progestin and estrogen
US6451778B1 (en) Oral contraceptive
EP0917466B1 (de) Orales contrazeptivum
EP0921804B1 (de) Biphasische orale verhuetungsmethode und kit die eine kombination von progestin und eines oestrogens enthalten
AU759925B2 (en) Oral contraceptive preparation having a first phase comprising progestin/estrogen and a second phase comprising progestin
WO1998004267A1 (en) Progestin/estrogen oral contraceptive
WO1998004266A1 (en) Oral contraceptive
WO1997041868A1 (en) Oral contraceptive
WO1997041870A1 (en) Oral contraceptive
WO1997041869A1 (en) Oral contraceptive
WO1997041872A1 (en) Oral contraceptive
WO1997041871A1 (en) Oral contraceptive
MXPA99000801A (en) Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen
MXPA99000883A (en) Oral contraceptive

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000124

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU NL PT SE

AX Request for extension of the european patent

Free format text: AL PAYMENT 20000124;LT PAYMENT 20000124;LV PAYMENT 20000124;MK PAYMENT 20000124;RO PAYMENT 20000124;SI PAYMENT 20000124

17Q First examination report despatched

Effective date: 20011008

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: WYETH

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61P 15/18 B

Ipc: 7A 61K 31/56 A

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61P 15/18 B

Ipc: 7A 61K 31/56 A

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20030925

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1028345

Country of ref document: HK